SCHEMBL6653285

SCHEMBL6653285

Cc1cccc([N+](=O)[O-])c1NC(=O)C(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 1/20 0.59
TDP1 Q9NUW8 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SMN1; SMN2 Q16637 6/20 0.49
TSHR P16473 4/20 0.49
LMNA P02545 5/20 0.48
HTT P42858 3/20 0.48
ALDH1A1 P00352 2/20 0.47
MAPK1 P28482 2/20 0.47
MAPT P10636 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GLA P06280 2/20 0.46
CES2 O00748 1/20 0.46
ABCB11 O95342 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
AR P10275 1/20 0.46
CHRM1 P11229 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11591038 0.84 KCNMA1 (0.65) KCNMA1TDP1L3MBTL1SMN1; SMN2TSHR
SCHEMBL30388557 0.83 KCNMA1 (0.63) KCNMA1TDP1L3MBTL1SMN1; SMN2TSHR
SCHEMBL5144247 0.83 KCNMA1 (0.63) KCNMA1TDP1L3MBTL1SMN1; SMN2TSHR
SCHEMBL12832472 0.82 ATM (0.60) L3MBTL1SMN1; SMN2LMNAHTTALDH1A1
SCHEMBL5528035 0.81 KCNMA1 (0.62) KCNMA1TDP1L3MBTL1SMN1; SMN2TSHR
SCHEMBL7321997 0.78 KCNMA1 (0.58) KCNMA1TDP1L3MBTL1SMN1; SMN2TSHR
SCHEMBL11227724 0.78 KCNMA1 (0.58) KCNMA1TDP1L3MBTL1SMN1; SMN2TSHR
SCHEMBL18725484 0.78 TSHR (0.55) KCNMA1TDP1L3MBTL1SMN1; SMN2TSHR
SCHEMBL9539950 0.77 KCNMA1 (0.57) KCNMA1TDP1L3MBTL1SMN1; SMN2TSHR
SCHEMBL27599949 0.77 KCNMA1 (0.56) KCNMA1TDP1L3MBTL1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1298706-C Insecticidal diamides DU PONT (US) 2007-02-07 CN disclosed
CN-1555364-A Insecticidal diamides �Ű˾ 2004-12-15 CN disclosed
US-20040235959-A1 Insecticidal diamides E. I. DU PONT DE NEMOURS AND COMPANY 2004-11-25 US disclosed
EP-1427705-A2 INSECTICIDAL DIAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2004-06-16 EP disclosed
WO-2003026415-A2 INSECTICIDAL DIAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2003-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040235959-A1 Insecticidal diamides DDT, NRDC, NOXO1 KCNMA1 1240/4885TDP1 2624/4885L3MBTL1 1347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.